Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.

Key facts

Study ID

NCT04237597

Run by

Kowa Research Institute, Inc.

People needed

20

Starts

2019-12-17

Expected to finish

2020-03-04

Last updated by the study team

2020-09-22

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject provides written informed consent before any study-specific evaluation is performed.
• Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive, at Screening.
• Subject has a BMI of 18 to 30 kg/m2, inclusive, at Screening.
• Subject meets all other inclusion criteria outlined in the clinical study protocol

You may not qualify if…

• Subject has clinically relevant abnormalities at Screening or at Check-in assessments.
• Subject is pregnant or breastfeeding or intends to become pregnant within 30 days after the last dose of study drug.
• Subject does not meet any other exclusion criteria outlined in the clinical study protocol.

Where it is running

• PPD Development. LP — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.